London-based scale-up Perci Health raises €4 million to scale AI-driven virtual cancer clinic

HealthTech scale-up Perci Health, a comprehensive virtual cancer clinic out of the UK, has successfully closed a €4 million funding round, double the original €2 million target and reaching a total of €10.4 million in funding.

This includes a €399k investment from Macmillan Cancer Support. Guinness Ventures and Conduit Fund have joined existing investors Octopus Ventures and 35 leading oncologists and cancer surgeons in backing Perci Health.

“Our mission to close the cancer care gap is powered by an outstanding team who are deeply committed to transforming the cancer care experience,” said Kelly McCabe, Co-Founder and CEO of Perci Health. “This investment will allow us to continue pioneering a model of care that integrates digital innovation with compassionate, specialist-led support, providing better outcomes for everyone living with and beyond cancer.”

Founded in 2020 by two female healthcare innovators: Kelly McCabe and Morgan Fitzsimons, Perci Health looks to redefine how cancer is managed, from prevention through to treatment and recovery.

As Co-founder and CEO, McCabe brings clinical expertise as a specialist oncology dietitian, with NHS hospital management experience and as the former COO of a network of private cancer facilities. Fitzsimons, Co-founder and Chief Customer Officer, applies her background in digital transformation and consumer experience, having held executive roles at CBS Television and ASOS.

The new funds will support the company’s plans to expand its AI-powered, multidisciplinary virtual cancer clinic, reaching more individuals and healthcare providers across the UK.

With a network of over 85 NHS-trained specialists, Perci Health aims to deliver highly personalised, flexible care that empowers patients to manage their condition and live well. Perci Health’s approach integrates digital innovation with human expertise to provide support.

“We’re incredibly impressed by the way Perci Health is tackling the gaps in cancer care with a human-first, tech-enabled model,” said Chantal Cox , Investor at Octopus Ventures. “This approach not only addresses pressing healthcare needs but also delivers measurable impact in terms of both clinical outcomes and cost-efficiency, which is vital for scaling the model across more insurers, employers, and health systems.”

With 100% of directors, 80% of its leadership team and 60% of its executive board composed of women, Perci Health stands as one of few UK scale-ups with an all-female founding team. Despite the fact that less than 2% of venture capital goes to female-led teams (according to data provided by the company), Perci Health has raised twice the average deal size for UK female-led startups in each of its funding rounds.

“Supporting businesses that are developing scalable, meaningful impact in healthcare is a priority for us,” said Eva-Maria Dimitriadis, Managing Partner at Conduit Fund. “Perci Health’s innovative, patient-centric model, combined with its strong leadership and growth potential, is precisely the kind of forward-thinking solution that we want to help grow. As a female led business ourselves – with a majority female investment team – we know female Founders statistically find it considerably more difficult to raise from VCs. We believe investing in female Founders is not just the right thing to do, but it gives us access to exceptional opportunities that others overlook. 42% of companies we have invested in have at least one female Founder and we are thrilled to add Perci Health to that list.”

Macmillan estimates that there are currently almost 3.5 million people living with cancer in the UK and this number will continue to rise, creating an urgent need for new, effective ways to support patients.

In the UK, cancer outcomes lag up to 25 years behind European peers, with 41% of staged diagnoses being at a late stage in England and around a third of eligible people missing critical screening appointments for breast, bowel and cervical cancer – as per data provided by Perci Health.

“Cancer survivorship presents unique challenges, and we must innovate to meet the growing needs of people living with and beyond cancer,” added Claire Taylor, Chief Nursing Officer, Macmillan Cancer Support. “Perci Health’s holistic, multidisciplinary approach is exactly the exciting innovation that is needed, and it aligns perfectly with Macmillan’s ambitions to help more people get the personalised care they need. This partnership represents a shared commitment to making a real difference in the lives of those affected by cancer, helping people to live well and by providing tailored solutions to meet their changing needs following a cancer experience.”

Improving these outcomes will require collaboration across the government, NHS, private insurers, charities, and employers, and Perci Health’s model aims to address these gaps by offering comprehensive care that spans prevention, early detection, treatment navigation, symptom management, and survivorship care.

“We know that cancer doesn’t stop when treatment ends. In fact, that’s often when people need the most support. Perci Health’s AI-driven platform ensures truly personalised care, enabling people to access the right support at the right time,” said Morgan Fitzsimons, Co-Founder and Chief Customer Officer.

This investment comes as the UK government increasingly prioritises vocational rehabilitation and reducing long-term sickness absence with the release of “Keep Britain Working Review”. Perci Health says they support these goals by enabling earlier intervention, personalised recovery plans, and return-to-work programmes that address both physical and psychological barriers.

“At Guinness Ventures, we look for Founders who are solving meaningful problems in an innovative way,” said Lisa Fox, Head of Co-Investment, Guinness Ventures. “Perci Health is doing exactly that in addressing one of the biggest and most underserved challenges in cancer care: how we support people after treatment ends. Their model combines clinical rigour with scalable technology, delivering meaningful outcomes not just for patients, but also for employers, insurers, and the broader healthcare ecosystem.”

“With more people living with cancer, there’s an urgent need for healthcare solutions that cater to long-term survivorship,” concludes McCabe. “By working with insurers, employers, and healthcare providers, we aim to reshape cancer care to ensure better outcomes for patients and cost savings for the system.”

The post London-based scale-up Perci Health raises €4 million to scale AI-driven virtual cancer clinic appeared first on EU-Startups.